What is an atypical hepatic adenoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Definition of Atypical Hepatic Adenoma

  • Atypical hepatic adenoma, also referred to as "atypical hepatocellular neoplasm" or "atypical adenoma", is a term used to describe hepatocellular adenoma-like neoplasms that show cytogenetic alterations similar to well-differentiated hepatocellular carcinomas 1.
  • These tumors often occur in unusual clinical settings, such as in men or older women, and may exhibit focal atypical morphologic features, making the distinction from well-differentiated hepatocellular carcinoma (HCC) challenging 1, 2.

Characteristics of Atypical Hepatic Adenoma

  • Atypical hepatic adenomas may have β-catenin activation, which is associated with atypical morphologic features and an increased risk of malignant transformation 1.
  • Cytogenetic changes typically observed in HCC are present in atypical hepatocellular neoplasms with β-catenin activation, suggesting that these tumors may represent an extremely well-differentiated variant of HCC 1.
  • The clinical, morphologic, immunohistochemical, molecular, and cytogenetic features of atypical hepatocellular neoplasms are distinct from those of typical hepatocellular adenoma and HCC 2.

Diagnosis and Management

  • The diagnosis of atypical hepatic adenoma is often made based on a combination of clinical, radiological, and pathological features 3, 4.
  • The management of atypical hepatic adenomas is based on a multidisciplinary approach, taking into account factors such as tumor size, subtype, and patient gender 3, 4, 5.
  • Surgical resection may be considered in cases where the risk of malignant transformation or bleeding is high, such as in tumors larger than 5 cm or those with β-catenin activation 4, 5.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.